#SyntheticBiology (#SynBio) has the potential to solve a wide range of global needs through breakthroughs in #Bioproduction, #Biosensing, #ClosedLoopMedicines, #CropProtection, and #ProbioticDelivery.

An analysis of GlobalData Plc #Disruptor #Deals database reveals that SynBio #VentureCapital (#VC) deals have surged over the past two years.

Reportedly low-cost #Biomanufacturing and #DNAsequencing methods have piqued the interest of investors in exploring SynBio’s potential applications in #FoodManufacturing and #Pharmaceuticals.

In fact, the total VC funding has surpassed $4bn by August 2021, primarily for bio ingredient development and #lifesciences research.

Stay on top of venture capital funding trends with some of the popular deals, areas where the smart money is flowing, and notable investors and accelerators pumping money into the technology growth. Get your hands on the report https://bit.ly/3H8wIsO